NASCOBAL (cyanocobalamin) Endo pharms inc Patent: 7,404,489 Expiration: Mar 12, 2024 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of March 10, 2024 Read Post »
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It
Annual Drug Patent Expirations for DALIRESP Daliresp is a drug marketed by Astrazeneca and is included in one NDA. It
New patent expiration for Astrazeneca drug DALIRESP Read Post »
Annual Drug Patent Expirations for ULORIC Uloric is a drug marketed by Takeda Pharms Usa and is included in one
New patent expiration for Takeda Pharms drug ULORIC Read Post »
Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one
New patent expiration for Alnylam Pharms drug GIVLAARI Read Post »
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA.
New patent expiration for Evofem Inc drug PHEXXI Read Post »
Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Abbvie and is included in two NDAs.
New patent expiration for Abbvie drug ALPHAGAN P Read Post »
Annual Drug Patent Expirations for FINACEA Finacea is a drug marketed by Leo Pharma As and is included in two
New patent expiration for Leo Pharma drug FINACEA Read Post »
Annual Drug Patent Expirations for DYMISTA Dymista is a drug marketed by Mylan Speciality Lp and is included in one
New patent expiration for Mylan Speciality drug DYMISTA Read Post »
Get fresh news and insights, drug patent expirations & more…
